News

Canada’s ETF Market Gets a Double Shot of Innovation
Detailed price information for Deltashares S&P 500 Managed Risk ETF (DMRL-A) from The Globe and Mail including charting and trades.
Ultragenyx Receives Complete Response Letter from FDA for UX111 AAV Gene Therapy to Treat Sanfilippo Syndrome Type A (MPS IIIA)
Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), today announced that the U.S. Food and Drug Administration (FDA) has issued a Complete Response Letter (CRL) for its Biologics License Application (BLA) ...
DIMERx Awarded Up to $15M by NIDA Under NIH HEAL Initiative® to Advance DMX-101 as a Non-Addictive Oral Therapy for Chronic Pain
The Award Highlights the Promise of Exclusively Targeting Peripheral Opioid Receptors to Treat Chronic Pain Without the Risk of Addiction and DependenceSAN FRANCISCO, June 25, 2025 (GLOBE NEWSWIRE) -- ...